Back to Single Peptide Protocols
Single PeptideMetabolic & Weight Loss10 mg vialWeeklySubcutaneousGLP-1
Semaglutide (10 mg Vial) Dosage Protocol
Detailed semaglutide dosage protocol with titration schedule and weekly injection guidance for the 10 mg research vial.
Vial Size
10 mg
Route
Subcutaneous
Frequency
Once weekly
Dose Range
0.25–2.4 mg/week
Dosage Schedule
| Period | Dose |
|---|---|
| Weeks 1–4 | 0.25 mg |
| Weeks 5–8 | 0.5 mg |
| Weeks 9–12 | 1.0 mg |
| Weeks 13+ | 1.7–2.4 mg |
Route: Subcutaneous · Frequency: Once weekly · Cycle: 12–52 weeks
How It Works
Semaglutide is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin sensitivity.
Potential Benefits
- •Clinically proven weight loss of 15–20% body weight.
- •Improves glycemic control in type 2 diabetes.
- •Cardiovascular risk reduction.
Side Effects & Risks
- •Nausea, vomiting, diarrhea (usually transient).
- •Risk of pancreatitis (rare).
Important Notes
- Titrate slowly to minimize GI side effects.
- FDA-approved for diabetes (Ozempic) and obesity (Wegovy).
Storage Instructions
- Lyophilized: −20 °C (−4 °F).
- Once mixed: 2–8 °C; use within 28 days.
References
- [1]Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021.View Source
Research & Educational Use Only: This protocol is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any decisions related to peptides or any other compounds.